LAMP2
protein-codinglysosomal associated membrane protein 2, the group of CD molecules|Lysosome associated membrane proteins
Gene summary
The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~43.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010281
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010281
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010281
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010281
Submitter: ClinGen
The LAMP2 gene is associated with Danon disease, an X-linked disorder characterized by vacuolar cardiomyopathy, and to a lesser extent skeletal myopathy, cognitive defects and retinopathy (reviewed in Rowland et al., 2016 PMID: 27165304). As an X-linked disorder males are predominantly affected but heterozygous female carriers have been shown to develop cardiomyopathy, albeit with abated progression compared to affected males (Boucek et al., 2011 PMID: 21415759). The majority of mutations are LOF (frameshift and non-sense) but missense, splice site, and large copy number variants (CNVs), both duplications and deletions, have been reported, as well as de novo mutations. LAMP2 has three different splice isoforms (LAMP-2A, LAMP-2B, LAMP-2C) due to alternative splicing in exon 9 (terminal exon). The LAMP-2B isoform is the most widely implicated in Danon Disease, as it is found to be most abundantly expressed in the heart, skeletal muscle and brain (Konecki et al., 1995 PMID: 7488019), but does not negate the other isoforms as having a role in disease. LAMP2 is the lysosomal-associated membrane protein 2 and functions as a receptor to mediate lysosomal associated degradation or proteins, or autophagy (reviewed in D’Souza et al., 2014, PMID: 25228319). Multiple cases are reported in the literature but the maximum score for genetic evidence (12 pts) has been reached. The mechanism for disease is disrupted autophagy that results in aberrant vacuole accumulation in cells. This gene-disease association is supported by the function of the gene product, alteration in normal function in non-patient cells, and animal models. In summary, LAMP2 is definitively associated with Danon disease. This association has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Data on the occurrence of cardiomyopathy in individuals with Danon disease was collected by the Hypertrophic Cardiomyopathy Gene Curation Committee (subgroup of the Cardiovascular Working Group). Mutation of LAMP2 results in the development of hypertrophic cardiomyopathy (in 88% of cases of Danon disease) that rapidly progresses to dilated cardiomyopathy (reviewed in Rowland et al., 2016 PMID: 27165304). The progression of cardiomyopathy is caused by aberrant accumulation of autophagic vacuoles in the heart and skeletal muscle. The progressive nature of LAMP2-associated cardiomyopathy requires heart transplantation by the third decade in order to avoid death (reviewed in D’Souza et al., 2014, PMID: 25228319).
Inheritance Pattern: XL
Disease ID:MONDO:0010281
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010281
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Neurologic
Intervention: Cardiovascular
Rationale: Surveillance (eg, with EKG and electrocardiogram) and medical management can help decrease morbidity related to cardiomyopathy and arrhythmias; Heart transplant has been suggested to be the only truly effective treatment
Comments: Males typically display mental retardation and other recognizable features, but females may be affected with cardiomyopathy and arrhthymias
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LAMP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002294.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 22 | 113 | 1 | 137 | |
| missense | 3 | 250 | 58 | 4 | 315 | |
| nonsense | 33 | 7 | 9 | 1 | 50 | |
| start loss | 2 | 4 | 6 | |||
| frameshift | 55 | 19 | 1 | 75 | ||
| splice donor/acceptor (+/-2bp) | 9 | 12 | 22 | 43 | ||
| Total | 102 | 43 | 304 | 171 | 6 | 626 |
Highest pathogenic variant AF is 9.1760796e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002285.1 | 9 | MANE Select | |
| Ensembl | ENSP00000200639.4 | 9 | MANE Select | |
| RefSeq | NP_001116078.1 | 9 | Standard | |
| RefSeq | NP_054701.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Phagosome - Homo sapiens (human)
- Autophagy - animal - Homo sapiens (human)
- Lysosome - Homo sapiens (human)
- Tuberculosis - Homo sapiens (human)
- Senescence and Autophagy in Cancer
Biological Process
- platelet degranulation
- protein targeting
- cellular response to starvation
- protein import
- regulation of protein stability
Molecular Function
- protein binding
- enzyme binding
- protein domain specific binding
Cellular Component
- extracellular space
- lysosome
- lysosomal membrane
- late endosome
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000434600
- Coding exons
- 9
- Length
- 41539
- Individuals with no LoFs
- 125723
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 4
- Defined
- 125728
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.840 | 116 | 144 | 0.803 | 0.00000998 | 2690 |
| Missense (PolyPhen) | 21 | 35.744 | 0.5875 | 717 | ||
| Synonymous | 1.06 | 43 | 52.8 | 0.815 | 0.00000356 | 818 |
| Loss of Function | 2.42 | 3 | 12.1 | 0.248 | 8.34e-7 | 231 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00018 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000024 | 0.000018 | rare |
| South Asian | 0.000052 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays an important role in chaperone-mediated autophagy, a process that mediates lysosomal degradation of proteins in response to various stresses and as part of the normal turnover of proteins with a long biological half-live (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125, PubMed:27628032). Functions by binding target proteins, such as GAPDH and MLLT11, and targeting them for lysosomal degradation (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125). Plays a role in lysosomal protein degradation in response to starvation (By similarity). Required for the fusion of autophagosomes with lysosomes during autophagy (PubMed:27628032). Cells that lack LAMP2 express normal levels of VAMP8, but fail to accumulate STX17 on autophagosomes, which is the most likely explanation for the lack of fusion between autophagosomes and lysosomes (PubMed:27628032). Required for normal degradation of the contents of autophagosomes (PubMed:27628032). Required for efficient MHCII-mediated presentation of exogenous antigens via its function in lysosomal protein degradation; antigenic peptides generated by proteases in the endosomal/lysosomal compartment are captured by nascent MHCII subunits (PubMed:20518820). Is not required for efficient MHCII-mediated presentation of endogenous antigens (PubMed:20518820). {ECO:0000250|UniProtKB:P17046, ECO:0000269|PubMed:11082038, ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:20518820, ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:27628032, ECO:0000269|PubMed:8662539}.;
- Disease
- DISEASE: Danon disease (DAND) [MIM:300257]: DAND is a lysosomal glycogen storage disease characterized by the clinical triad of cardiomyopathy, vacuolar myopathy and mental retardation. It is often associated with an accumulation of glycogen in muscle and lysosomes. {ECO:0000269|PubMed:15673802, ECO:0000269|PubMed:15907287}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.618
Intolerance Scores
- RVIS EVS
- 0.11
- RVIS percentile EVS
- 61.73
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.150
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |